ARCHIVES

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 31 | August 4, 1995

Download PDF Visit The Full Archive

Related Articles

First CCOP 3 Returns In; Payline Not Yet Determined; Goes to NCAB On Jan. 30

January 26, 1990

Congress Passes NIH Reauthorization.

December 15, 2006

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Durant Suggests Six Efforts Needed For Survival Of Clinical Research

May 30, 1986

NIH Negotiating On Straus Grant; Committee Asks for One Probe

July 17, 1981

New Risk Stratification Method For Prostate Cancer Described

November 28, 2003